Back to search

Article

Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022

2022-06-29

Abstract excerpt

We included 852 patients in a prospectively recruiting multicenter matched case-control study in Germany to assess vaccine effectiveness (VE) in preventing COVID-19-associated hospitalization (Delta-variant dominance). Two-dose VE was 89% (95%CI 84-93%) overall, 79% in patients with >2 comorbidities and 77% in adults aged 60-75 years. A third dose increased VE to >93% in all patient-subgroups.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef8605aa-1029-5c36-ac7f-99e302b4ec86
DOI
10.1101/2022.06.28.22276303
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022DOI 10.1101/2022.06.28.22276303
Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity
Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021Semantic proximity
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational StudySemantic proximity
Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity
Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in FranceSemantic proximity
COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United StatesSemantic proximity
Risk factors for COVID-19 hospitalization or death during the first Omicron surge in adults: a large population-based case-control studySemantic proximity
Effectiveness of COVID-19 Vaccines Against Hospitalization in Latin America During Three Pandemic Waves, 2021-2022: A Test-Negative Case-Control DesignSemantic proximity
Retrospective analysis of vaccination status and predominant viral variants in patients hospitalized with COVID-19 in Reus, SpainSemantic proximity
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United StatesSemantic proximity
Retrospective cohort study of COVID-19 in patients of the Brazilian public health system with SARS-COV-2 Omicron variant infectionSemantic proximity
Select a neighboring publication to make it the new centre.